BIOMAT Database Logo BIOMAT Database Logo

High-dose intermittent intravenous infusion of procarbazine (NSC-77213). 1973

B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
Procarbazine (NSC-77213) and multiple myeloma.
August 1970, Cancer chemotherapy reports,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
Preclinical toxicologic study of procarbazine (NSC-77213).
January 1973, Cancer chemotherapy reports. Part 3,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
Response of childhood histiocytosis X to procarbazine (NSC-77213).
January 1974, Cancer chemotherapy reports,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
March 1976, Cancer treatment reports,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
Procarbazine (NSC-77213) in the treatment of advanced bronchogenic carcinoma.
April 1969, Cancer chemotherapy reports,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
Treatment of advanced Hodgkin's disease with vinblastine (NSC-49842) or procarbazine (NSC-77213).
February 1969, Cancer chemotherapy reports,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
Treatment of malignant melanoma with vinblastine (NSC-49842), procarbazine (NSC-77213), and actinomycin D (NSC-3053).
January 1975, Cancer chemotherapy reports,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
Letter: An evaluation of procarbazine (NSC-77213) in the treatment of acute leukemia.
January 1973, Cancer chemotherapy reports,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lung.
October 1970, Cancer chemotherapy reports,
B A Chabner, and R Sponzo, and S Hubbard, and G P Canellos, and R C Young, and P S Schein, and V T Devita
Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.
January 1975, Cancer chemotherapy reports,
Copied contents to your clipboard!